1,200 articles
Giuseppe Curigliano
Giuseppe Curigliano is an Italian medical oncologist who leads early drug development at the European Institute of Oncology in Milan and specializes in breast cancer.
Giuseppe Giaccone
Giuseppe Giaccone is an Italian-born medical oncologist specializing in lung cancer, thymic tumors, and mesothelioma, who led the National Cancer Institute's Medical Oncology Branch from 2007 to 2012.
Glenn Dranoff
Glenn Dranoff is a physician-scientist and cancer immunologist known for GM-CSF-secreting therapeutic cancer vaccines, a professor at Dana-Farber and Harvard who led Novartis immuno-oncology research from 2015 to 2023.
Gordon Peters
Gordon Peters (1948–2016) was a British molecular biologist at the Imperial Cancer Research Fund and Cancer Research UK, known for identifying the int-2 locus and the INK4a/ARF tumor suppressor locus.
Gordon Rustin
Gordon J.S. Rustin is a British medical oncologist known for trials in gynecological cancer and germ-cell tumors and for CA125 research at Charing Cross and Mount Vernon hospitals.
Gordon Zubrod
Charles Gordon Zubrod (1914–1999) was an American oncologist who, as clinical and scientific director of the National Cancer Institute, built the cooperative clinical trials system through which childhood leukemia became largely curable.
Graham A. Colditz
Graham A. Colditz is an Australian-born cancer epidemiologist at Washington University School of Medicine in St. Louis, known for linking postmenopausal hormone therapy to breast cancer risk and for breast cancer risk prediction models.
Grantley W. Taylor
Grantley W. Taylor, full name Grantley Walder Taylor, was an American surgeon and cancer researcher at Harvard and Massachusetts General Hospital, known for work on lymph-node metastases and hindquarter amputation.
Gregory R. Mundy
Gregory R. Mundy (1942–2010) was an Australian-born physician-scientist who showed that cancer destroys bone indirectly by activating osteoclasts, credited with discovering osteoclast activating factor and directing Vanderbilt's Center in Bone Biology.
Gregory T. Armstrong
Gregory T. Armstrong, known as Greg Armstrong, is an American pediatric oncologist and epidemiologist at St. Jude Children's Research Hospital in Memphis, principal investigator of the Childhood Cancer Survivor Study.
Gregory Y. Lauwers
Gregory Y. Lauwers is a gastrointestinal pathologist who led GI pathology at Massachusetts General Hospital and Harvard from 2000 to 2016 and is now a Senior Member at Moffitt Cancer Center in Tampa.
Guido Kroemer
Guido Kroemer, born 1961, is an Austrian-Spanish cell biologist and cancer researcher working in Paris, known for discovering how mitochondrial membrane permeabilization ignites cell death and for the concept of immunogenic cell death.
Gunnar Steineck
Gunnar Steineck was a Swedish physician and professor of clinical cancer epidemiology at Karolinska Institutet and the University of Gothenburg, known for patient-reported outcome research among cancer survivors.
Gustavo Leone
Gustavo Leone is an American cancer biologist known for work on Rb/E2F and PTEN signaling and cell cycle control, and director of the MCW Cancer Center since 2020.
Guy B. de The
Guy B. de The, full name Guy Blaudin de Thé (1930–2014), was a French virologist at the Institut Pasteur whose studies proved the Epstein–Barr virus causes Burkitt's lymphoma.
H. Michael Shepard
H. Michael Shepard is an American cancer biologist who led the Genentech team that developed trastuzumab (Herceptin) for HER2-positive breast cancer, winning the 2019 Lasker Award.
Hagop M. Kantarjian
Hagop M. Kantarjian is a Lebanese-born hematologist-oncologist at MD Anderson Cancer Center, chair of its leukemia department from 1995 to 2025 and a critic of cancer drug prices.
Haidong D. Dong
Haidong D. Dong is a physician-scientist and Professor of Immunology at Mayo Clinic, best known for discovering B7-H1 and showing tumor-cell B7-H1 promotes T-cell apoptosis.
Hanlee P. Ji
Hanlee P. Ji, often published as Hanlee Ji, is a Stanford professor of medicine (oncology) known for developing DNA sequencing technologies for cancer genomics and precision oncology.
Hans Lehrach
Hans Lehrach, born in 1946 in Vienna, is a German geneticist and genome researcher, director at the Max Planck Institute for Molecular Genetics in Berlin.
Hans‐Joachim Schmoll
Hans-Joachim Schmoll is a German medical oncologist who led cancer research at Hannover and Halle, developed colorectal cancer treatments, and wrote ESMO consensus guidelines, winning the 2020 ESMO Award.
Hans‐Olov Adami
Hans-Olov Adami is a Swedish physician and cancer epidemiologist, trained as a surgeon, who led Karolinska Institutet's Department of Medical Epidemiology and Biostatistics from 1997 to 2008.
Harald zur Hausen
Harald zur Hausen (1936–2023) was a German virologist who established that HPV causes most cervical cancer, earning half of the 2008 Nobel Prize in Physiology or Medicine.
Harold E. Johns
Harold E. Johns (Harold Elford Johns) was a Canadian medical physicist who led the design of one of the first cobalt-60 cancer therapy units, the "cobalt bomb", in 1951.
Harold E. Varmus
Harold E. Varmus (born 1939) is an American oncologist who shared the 1989 Nobel Prize with J. Michael Bishop for discovering the cellular origin of retroviral oncogenes, and later directed NIH, Memorial Sloan Kettering, and the NCI.
Harold J. Burstein
Harold J. Burstein is an American medical oncologist specializing in breast cancer, a professor at Harvard Medical School, and a Dana-Farber clinician known for NEJM reviews and treatment guidelines.
Harold J. Wanebo
Harold J. Wanebo was an American surgical oncologist at Roger Williams Medical Center in Rhode Island, known for linking blood tests and tumor depth to cancer prognosis.
Harold P. Freeman
Harold P. Freeman was an American surgical oncologist who pioneered patient navigation for poor and uninsured cancer patients, founding the first navigator program in Harlem in 1990.
Hashem B. El‐Serag
Hashem B. El-Serag is a Palestinian-born American gastroenterologist at Baylor College of Medicine who studies liver cancer and served as president of the American Gastroenterological Association in 2019.
Hedy L. Kindler
Hedy L. Kindler, also known as Hedy Lee Kindler, is an American medical oncologist at the University of Chicago known for mesothelioma research and the POLO pancreatic cancer trial.